The Long-Term Benefits of Interventions to Improve T2D Outcomes

改善 T2D 结局的干预措施的长期益处

基本信息

  • 批准号:
    9321379
  • 负责人:
  • 金额:
    $ 65.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-22 至 2020-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary/ Abstract Diabetes is a mounting public health concern, with millions of new cases each year. Poor control of diabetes is associated with serious health complications, including heart disease, blindness, and amputation. Control of diabetes can be achieved through adherence to diet, exercise, and treatment guidelines, but compliance with prescribed regimens can be complicated and difficult. The Look AHEAD study randomized an intensive lifestyle intervention focused on weight reduction among over 5,000 patients with type 2 diabetes in 2001. Participants in the intervention lost weight and improved their diabetes control over the 11 years of the intervention relative to the control group. Weight reductions and improvements in diabetes outcomes may lead to broader benefits for patients in terms of functional status, ability to work, and fewer health complications. We propose research linking Look AHEAD participants with data from Medicare and the Social Security Administration to determine the effect of the intervention on long-term health care utilization (e.g. hospital admissions), employment, earnings, retirement, and severe disability (as measured by enrollment in disability insurance). In addition, we will simulate the long-term fiscal impacts of a broader, national expansion of the intensive lifestyle intervention. Finally, we will compare health and disability measures collected by the Look AHEAD study to overlapping measures in Medicare and the Social Security Administration data, to evaluate the use of administrative data as a source of health information in clinical trials. The results of this study will provide important evidence on the broader benefits of successful lifestyle interventions for diabetes. In addition, the results will indicate the impact of improved diabetes control on functional status and economic outcomes.
项目总结/摘要 糖尿病是一个日益严重的公共卫生问题,每年有数百万新病例。糖尿病控制不佳是 与严重的健康并发症有关,包括心脏病、失明和截肢。控制 糖尿病可以通过坚持饮食,锻炼和治疗指南来实现,但遵守 规定的治疗方案可能复杂而困难。Look AHEAD研究随机分配了一个密集的 2001年,生活方式干预的重点是减轻5 000多名2型糖尿病患者的体重。 在11年的干预中,参与者体重减轻,糖尿病控制得到改善。 相对于对照组的干预。体重减轻和糖尿病结局的改善可能导致 在功能状态、工作能力和更少的健康并发症方面为患者带来更广泛的益处。我们 建议将Look AHEAD参与者与Medicare和Social Security的数据联系起来 管理,以确定干预对长期卫生保健利用的影响(例如,医院 入学),就业,收入,退休和严重残疾(通过残疾登记来衡量) 保险)。此外,我们还将模拟更广泛的国家扩张对财政的长期影响。 强化生活方式干预。最后,我们将比较Look收集的健康和残疾指标 AHEAD研究医疗保险和社会保障管理局数据中的重叠措施,以评估 在临床试验中使用管理数据作为健康信息的来源。这项研究的结果将 为糖尿病成功的生活方式干预的更广泛益处提供了重要证据。在 此外,研究结果将表明改善糖尿病控制对功能状态和经济的影响。 结果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DANA P GOLDMAN其他文献

DANA P GOLDMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DANA P GOLDMAN', 18)}}的其他基金

Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Dementias (CeASES-ADRD)
阿尔茨海默病及相关痴呆症社会人口学和经济研究推进中心 (CeASES-ADRD)
  • 批准号:
    10216946
  • 财政年份:
    2020
  • 资助金额:
    $ 65.95万
  • 项目类别:
Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Dementias (CeASES-ADRD)
阿尔茨海默病及相关痴呆症社会人口学和经济研究推进中心 (CeASES-ADRD)
  • 批准号:
    10417203
  • 财政年份:
    2020
  • 资助金额:
    $ 65.95万
  • 项目类别:
Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Dementias (CeASES-ADRD)
阿尔茨海默病及相关痴呆症社会人口学和经济研究推进中心 (CeASES-ADRD)
  • 批准号:
    10657377
  • 财政年份:
    2020
  • 资助金额:
    $ 65.95万
  • 项目类别:
Precision Medicine: Moving Theory into Practice
精准医学:将理论付诸实践
  • 批准号:
    9752826
  • 财政年份:
    2019
  • 资助金额:
    $ 65.95万
  • 项目类别:
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
确保获得新型阿尔茨海默病和痴呆症治疗方法:评估创新的支付方式
  • 批准号:
    9977782
  • 财政年份:
    2018
  • 资助金额:
    $ 65.95万
  • 项目类别:
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
确保获得新型阿尔茨海默病和痴呆症治疗方法:评估创新的支付方式
  • 批准号:
    10176332
  • 财政年份:
    2018
  • 资助金额:
    $ 65.95万
  • 项目类别:
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
确保获得新型阿尔茨海默病和痴呆症治疗方法:评估创新的支付方式
  • 批准号:
    9789172
  • 财政年份:
    2018
  • 资助金额:
    $ 65.95万
  • 项目类别:
The Long-Term Benefits of Interventions to Improve T2D Outcomes
改善 T2D 结局的干预措施的长期益处
  • 批准号:
    9176837
  • 财政年份:
    2016
  • 资助金额:
    $ 65.95万
  • 项目类别:
USC Resource Center for Minority Aging Research (US-RCMAR)
南加州大学少数民族老龄化研究资源中心 (US-RCMAR)
  • 批准号:
    8987153
  • 财政年份:
    2015
  • 资助金额:
    $ 65.95万
  • 项目类别:
Technological Innovation in Health Care and the Long-Term Fiscal Outlook
医疗保健技术创新和长期财政前景
  • 批准号:
    8750769
  • 财政年份:
    2014
  • 资助金额:
    $ 65.95万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 65.95万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 65.95万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 65.95万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 65.95万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 65.95万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 65.95万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 65.95万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 65.95万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 65.95万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 65.95万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了